These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 7298759

  • 21. Determination of specific urinary hydroxyproline-containing peptides in patients with lung cancer.
    Svojtková E, Macek K, Deyl Z, Adam M.
    J Chromatogr; 1980 Aug 08; 183(2):221-5. PubMed ID: 7400280
    [No Abstract] [Full Text] [Related]

  • 22. Comparison of serum osteocalcin with total and bone specific alkaline phosphatase and urinary hydroxyproline:creatinine ratio in patients with Paget's disease of bone.
    Kaddam IM, Iqbal SJ, Holland S, Wong M, Manning D.
    Ann Clin Biochem; 1994 Jul 08; 31 ( Pt 4)():327-30. PubMed ID: 7979096
    [Abstract] [Full Text] [Related]

  • 23. Evaluation of a new technique for measuring bone formation.
    Kalu DN.
    Med Lab Technol; 1975 Apr 08; 32(2):91-8. PubMed ID: 1160810
    [No Abstract] [Full Text] [Related]

  • 24. [Studies of variations in several biological parameters in Paget's disease (phosphatases, hydroxyproline...) before and after treatment with aspirin].
    Galmiche P, Lévy P.
    Rev Rhum Mal Osteoartic; 1967 Apr 08; 34(4):185-92. PubMed ID: 6059924
    [No Abstract] [Full Text] [Related]

  • 25. [Deoxypyridinoline and other biochemical markers of bone resorption in distinct pathologies].
    Rivero Marcotegui A, Palacios Sarrasqueta M, Grijalba Uche A, Martínez Rodríguez JL, Sorbet Zubiría MJ, García Merlo S.
    Rev Clin Esp; 1997 Jun 08; 197(6):389-92. PubMed ID: 9304127
    [Abstract] [Full Text] [Related]

  • 26. Automated analysis of hydroxyproline with elimination of non-specific reacting substances.
    Verch RL, Wallach S, Peabody RA.
    Clin Chim Acta; 1979 Aug 15; 96(1-2):125-30. PubMed ID: 476953
    [Abstract] [Full Text] [Related]

  • 27. Abnormal hydroxyproline polypeptides in the urine of patients with chronic uremia.
    Dubovsky J, Meyer RD.
    Nephron; 1976 Aug 15; 17(1):20-7. PubMed ID: 934411
    [Abstract] [Full Text] [Related]

  • 28. Urinary excretion of hydroxylysine and its glycosides as an index of collagen degradation.
    Krane SM, Kantrowitz FG, Byrne M, Pinnell SR, Singer FR.
    J Clin Invest; 1977 May 15; 59(5):819-27. PubMed ID: 404321
    [Abstract] [Full Text] [Related]

  • 29. [The significance of the excretion of amino acids and acid mucopolysaccharides in the urine in orthopedic diseases].
    Kaiser G, Kyselka R, Mühlbach R, Hirthe D, Beck O, Schramm G, Lindenhayn K.
    Beitr Orthop Traumatol; 1969 Oct 15; 16(10):545-52. PubMed ID: 4246720
    [No Abstract] [Full Text] [Related]

  • 30. Letter: Plasma-phosphate in Paget's disease.
    Bijvoet OL, de Vries HR.
    Lancet; 1974 Jun 22; 1(7869):1283-4. PubMed ID: 4134160
    [No Abstract] [Full Text] [Related]

  • 31. Evidence of a generalised connective-tissue defect in Paget's disease of bone.
    Francis MJ, Smith R.
    Lancet; 1974 May 04; 1(7862):841. PubMed ID: 4132793
    [No Abstract] [Full Text] [Related]

  • 32. An automatic technique for the routine fractionation of the urinary hydroxyproline containing peptides.
    Szymanovicz A, Joubert PM, Garbe A, Randoux A, Borel JP.
    Clin Chim Acta; 1980 Jan 15; 100(2):155-64. PubMed ID: 7351087
    [Abstract] [Full Text] [Related]

  • 33. Nondialyzable urinary hydroxyproline as an index of bone collagen formation.
    Haddad JG, Couranz S, Avioli LV.
    J Clin Endocrinol Metab; 1970 Mar 15; 30(3):282-7. PubMed ID: 4983851
    [No Abstract] [Full Text] [Related]

  • 34. [Relations between urine excretion of hydroxyproline and alkaline serum phophatase in Paget's disease as expression of changes in collagen metabolism].
    Mühlbach R.
    Beitr Orthop Traumatol; 1966 Apr 15; 13(4):189-96. PubMed ID: 5927636
    [No Abstract] [Full Text] [Related]

  • 35. Treatment of Paget's disease with a diphosphonate (sodium etidronate).
    Smith R, Russell RG.
    Semin Drug Treat; 1972 Apr 15; 2(1):77-81. PubMed ID: 4558759
    [No Abstract] [Full Text] [Related]

  • 36. Paget's disease of bone (osteitis deformans) treated with human synthetic calcitonin.
    Epstein S, Owen G.
    S Afr Med J; 1977 Jan 29; 51(5):133-7. PubMed ID: 850845
    [Abstract] [Full Text] [Related]

  • 37. The urinary excretion of inorganic pyrophosphate in hyperparathyroidism, hyperthyroidism, Paget's disease and other disorders of bone metabolism.
    Russell RG, Hodgkinson A.
    Clin Sci; 1969 Jun 29; 36(3):435-43. PubMed ID: 4307562
    [No Abstract] [Full Text] [Related]

  • 38. Treatment of Paget's disease of bone with synthetic human calcitonin: biochemical and roentgenologic changes.
    Greenberg PB, Doyle FH, Fisher MT, Hillyard CJ, Joplin GF, Pennock J, MacIntyre I.
    Am J Med; 1974 Jun 29; 56(6):867-70. PubMed ID: 4831323
    [No Abstract] [Full Text] [Related]

  • 39. Newer agents in treating Paget's disease of bone.
    Goldfield EB.
    Geriatrics; 1974 Dec 29; 29(12):61-9. PubMed ID: 4279196
    [No Abstract] [Full Text] [Related]

  • 40. [Fractionation of hydroxyproline-containing urinary peptides by Sephadex gel filtration].
    Hanson H, Wiederanders B.
    Clin Chim Acta; 1969 Aug 29; 25(2):255-62. PubMed ID: 5801391
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.